| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 13.502 | 52.838 | 78.685 | 101.946 | 153.301 | 232.610 | 206.565 | 169.106 | 198.106 | 229.061 |
| Total Income - EUR | 13.763 | 54.068 | 79.592 | 102.689 | 154.991 | 243.162 | 217.070 | 170.583 | 204.627 | 229.812 |
| Total Expenses - EUR | 11.223 | 45.978 | 68.170 | 88.952 | 147.723 | 201.423 | 165.664 | 149.269 | 168.585 | 190.264 |
| Gross Profit/Loss - EUR | 2.540 | 8.090 | 11.422 | 13.736 | 7.268 | 41.739 | 51.406 | 21.313 | 36.042 | 39.548 |
| Net Profit/Loss - EUR | 2.130 | 7.501 | 10.513 | 12.717 | 5.734 | 39.575 | 49.286 | 19.649 | 34.264 | 33.912 |
| Employees | 1 | 2 | 3 | 2 | 3 | 4 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Pharmacid International Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 49 | 7.604 | 16.888 | 11.295 | 11.946 | 10.626 | 2.499 | 798 | 19.571 | 13.900 |
| Current Assets | 10.310 | 20.376 | 36.012 | 36.097 | 38.433 | 92.731 | 54.567 | 45.445 | 65.365 | 59.069 |
| Inventories | 1.314 | 10.154 | 17.437 | 20.750 | 11.599 | 43.982 | 31.860 | 33.143 | 46.287 | 39.903 |
| Receivables | 1.732 | 6.186 | 17.114 | 14.669 | 24.115 | 24.712 | 17.815 | 11.902 | 18.217 | 12.107 |
| Cash | 7.265 | 4.036 | 1.460 | 678 | 2.719 | 24.038 | 4.892 | 399 | 861 | 7.060 |
| Shareholders Funds | 6.823 | 14.255 | 24.527 | 33.401 | 33.099 | 66.389 | 50.472 | 19.902 | 52.288 | 34.163 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.536 | 13.808 | 29.002 | 14.383 | 17.875 | 37.758 | 7.823 | 27.920 | 35.186 | 40.499 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Pharmacid International Srl